This is the third and final part of a blog series that delves into the different features included in Total Health and how they might apply to a healthcare professional. This blog focuses on clinical consults, how they work and the variety of benefits they provide for patients.
This is the second part of a blog series that delves into the different features included in Total Health and how they might apply to a healthcare professional. This blog focuses on the blood testing panel, how 23andMe approaches it slightly differently, and how it impacts clinical decision-making.
This is the first part of a blog series that delves into the different features included in Total Health and how they might apply to a healthcare professional. This blog focuses on exome sequencing, the technology behind it, how it differs from genotyping and its application within clinical decision making.
Enhance your genetics curriculum for medical students with the integration of 23andMe's genetics education program, addressing gaps in genetics education.
Discover the limitations of ethnicity-based carrier screening. Learn how a new study found that these guidelines miss over half of carriers for serious genetic conditions.
Learn about common 'red flags' in a family history that might indicate a familial or hereditary condition and receive guidance on how and when to respond with a discussion around genetic testing or a referral to a genetics specialist. Family health history can also prompt discussions around lifestyle modifications, health screenings and monitoring.
Family history should be collected during annual wellness visits. Find out what type of information to collect from your patients, which details matter, and how genetic information from family history and DTC testing can help inform your patients' personal identity and health risks. Included are key parts of a family health history and various ways to collect the information.
Genetics is a big reason why patients may respond differently to commonly prescribed medications. Yet few of them are screened to detect these genetic differences. 23andMe in collaboration with Osmosis from Elsevier developed this short animated video to help healthcare professionals like you learn the about the fundamentals of pharmacogenetics/pharmacogenomics.
This week 23andMe scientists published findings from the first four months of our COVID-19 study using data from more than a million research participants that found both genetic and non-genetic associations for susceptibility and severity to COVID-19.
Today, 23andMe added a new Genetic Health Risk report on APOL1-related chronic kidney disease that has particular relevance for customers with African ancestry.
